Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: J Inorg Biochem. 2012 Jan 31;111:182–186. doi: 10.1016/j.jinorgbio.2011.12.013

Table 1.

EXAFS curve fitting results for Zn- and Co-BcII.a

Fit 4 M-N/O     0.5 M-S 2 2 M-Hisb M-M % ISc % IMd Refined
M-M CN
Zn
0.5
1.0
2.0

2.02 (5.0)     2.28 (8.0)
2.03 (6.6)     2.28 (6.0)
2.03 (6.3)     2.27 (2.6)

2.95 (1.6) 3.21 (5.0) 4.12 (9.0) 4.41 (21)
2.93 (0.6) 3.18 (2.0) 4.08 (13) 4.44 (14)
2.90 (3.1) 3.18 (5.8) 4.08 (11) 4.43 (15)

3.41 (13)
3.41 (10)
3.42 (8.3)

37
36
41

24
30
47

0.12
0.30
0.91
Co
0.5
1.0
2.0

2.03 (6.9)     2.30 (1.7)
2.06 (6.1)     2.30 (3.7)
2.09 (1.3)     2.31 (5.4)

2.94 (4.2) 3.24 (15) 4.03 (12) 4.28 (18)
2.94 (2.2) 3.25 (14) 4.02 (10) 4.28 (16)
2.93 (1.8) 3.19 (14) 4.08 (14) 4.32 (12)

3.56 (8.8)
3.55 (6.0)
3.55 (5.4)

79
61
23

39
43
27

0.15
0.33
0.96
a

Distances (Å) and disorder parameters (in parentheses, σ2 (10−3 Å2)) shown derive from integer or half-integer coordination number fits to filtered EXAFS data [k = 1.5–12.5 Å−1; R = 0.2–4.2 Å].

b

Imidazole multiple scattering paths represent combined paths, as described previously (see Materials and Methods).

c

Percentage reduction of the fit residual for a first shell fit that includes 0.5 S scatterers over one that utilizes only N/O scatterers (% IS). See Supporting Information for details.

d

Percentage reduction of the fit residual for a fit that includes 4 N/O and 0.5 S scatterers in the first shell, the outer shell scattering from two coordinated imidazoles and a metal-metal vector, compared to one that lacks the metal-metal vector (% IM). See Supporting Information for details.